Cerenome, Inc. (CNSY) News
Follow Cerenome, Inc. (CNSY) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 9 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Cerenome, Inc. (CNSY) Sees Preliminary Q3 CNSide Gross Billings of $1.55M
Cerenome reported preliminary Q3 2026 CNSide gross billings of $1.55M, noting gross billings are not GAAP revenue and may differ from final results.Material DetailsContext by AI AnalystThis is an early datapoint on build
EARNINGS | Sep 30, 2026, 11:38 AM UTC
L
Cerenome Expects $1.55 Million in CNSide® Third Quarter Gross Billings
Lead test on track for 200 million covered lives and beneficiaries by early 2027 after CMS meetingOn track to launch expanded CNSide testing menu with multiple tests in Q4 2026HOUSTON, Sept. 30, 2026 (GLOBE NEWSWIRE) --
NEWS | Sep 30, 2026, 11:38 AM UTC
L
Cerenome to Hold CNSide® Business Update Call on September 30, 2026
Management to provide updates on recent developments including diagnostic billing, market access & growth plansHOUSTON, Sept. 25, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Cerenome, I
NEWS | Sep 25, 2026, 11:31 AM UTC
M
Cerenome adds BCBS Michigan in-network for CNSide from Sept. 1, 2026
Blue Cross Blue Shield of Michigan added CNSide in-network effective Sept. 1, 2026, expanding contracted reimbursement coverage to about 158 million commercial and Medicare Advantage lives.
EQUITY | Sep 22, 2026, 11:33 AM UTC
M
Cerenome subsidiary signs in-network deal with BCBSM for CNSide coverage
CNSide Diagnostics, a Cerenome subsidiary, signed an in-network provider agreement with Blue Cross Blue Shield of Michigan effective September 1, expanding CNSide® contracted coverage to about 158 million covered lives.
EQUITY | Sep 22, 2026, 11:32 AM UTC
L
CNSY - Cerenome Secures In-Network Agreement with Blue Cross Blue Shield of Michigan, Expanding CNSide® Contracted Coverage to Approximately 158 Million Covered Lives
CNSY - Cerenome Secures In-Network Agreement with Blue Cross Blue Shield of Michigan, Expanding CNSide® Contracted Coverage to Approximately 158 Million Covered Lives
NEWS | Sep 22, 2026, 11:30 AM UTC
L
CNSY - Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division
CNSY - Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division
NEWS | Sep 16, 2026, 11:30 AM UTC
L
Cerenome launches $21.3M senior secured convertible notes; $3.0M expected to close Sep 10, 2026
Cerenome announced a senior secured convertible note program totaling $21.3 million in original principal. An initial $3.0 million closing is expected on September 10, 2026, with 8% interest and a 6% original issue disco
EQUITY | Sep 10, 2026, 12:04 PM UTC
M
Cerenome announces up to $20 million financing facility with royalty-based repayment
Cerenome said the capital will support continued CNSide® commercial scale-up and development. The initial funding tranche is provided at closing, with future tranches tied to milestones, and it expects forecasted cash ru
EQUITY | Sep 10, 2026, 11:21 AM UTC